MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.
Song Shi(Peking University), Jianyuan Luo(Peking University), Miao Yu(Peking University), Feng Li(Peking University), Xiaojuan Du(Peking University), Mengmeng Ren(Xi'an Jiaotong University), Boya Liu(Boston Children's Hospital), Junhua Zou(Peking University), Zhe Wang(Cancer Genetics (United States)), Hongquan Zhang(Ministry of Education of the People's Republic of China), Minghui Liu(Peking University), Hao Qi(Peking University), Yuxia Yang(Peking University), Xin Yang(Cancer Genetics (United States))
PubMed
January 1, 2018
Cited by 42
Related Papers
Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency
|Cell|2017|516
Mitochondrial dysfunction: roles in skeletal muscle atrophy
|Journal of Translational Medicine|2023|275
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
|Cancer Research|2017|237
MXene-derived TiO<sub>2</sub>/reduced graphene oxide composite with an enhanced capacitive capacity for Li-ion and K-ion batteries
|Journal of Materials Chemistry A|2019|220
The efficacy of virtual reality exposure therapy for PTSD symptoms: A systematic review and meta-analysis
|Journal of Affective Disorders|2019|189